Clinical Trials
5 trialsNCT07446855 2026-05-26
PARTHENON
AstraZeneca
Phase 1/2 Recruiting
NCT07160725 2026-05-15
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Recruiting
NCT06725758 2026-05-08
TEADES
Orion Corporation, Orion Pharma
Phase 1/2 Recruiting
NCT06581432 2026-04-29
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Boehringer Ingelheim
Phase 2 Recruiting
NCT06619509 2026-04-14
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
Boehringer Ingelheim
Phase 2 Active not recruiting